Michael Huang's most recent trade in Soleno Therapeutics Inc was a trade of 812 Common Stock done at an average price of $49.9 . Disclosure was reported to the exchange on Dec. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.95 per share. | 15 Dec 2025 | 812 | 36,005 (0%) | 0% | 49.9 | 40,559 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.93 per share. | 27 Mar 2025 | 10,000 | 46,817 (0%) | 0% | 21.9 | 219,300 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Sale of securities on an exchange or to another person at price $ 70.03 per share. | 27 Mar 2025 | 10,000 | 36,817 (0%) | 0% | 70.0 | 700,330 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 10,000 | 110,000 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Sale of securities on an exchange or to another person at price $ 68.79 per share. | 27 Mar 2025 | 1,444 | 37,883 (0%) | 0% | 68.8 | 99,330 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Sale of securities on an exchange or to another person at price $ 67.70 per share. | 27 Mar 2025 | 1,098 | 39,327 (0%) | 0% | 67.7 | 74,335 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Sale of securities on an exchange or to another person at price $ 69.84 per share. | 27 Mar 2025 | 836 | 37,047 (0%) | 0% | 69.8 | 58,384 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Sale of securities on an exchange or to another person at price $ 66.79 per share. | 27 Mar 2025 | 604 | 40,425 (0%) | 0% | 66.8 | 40,342 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Sale of securities on an exchange or to another person at price $ 65.97 per share. | 27 Mar 2025 | 371 | 41,029 (0%) | 0% | 66.0 | 24,475 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Sale of securities on an exchange or to another person at price $ 71.74 per share. | 27 Mar 2025 | 125 | 36,836 (0%) | 0% | 71.7 | 8,968 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Sale of securities on an exchange or to another person at price $ 70.73 per share. | 27 Mar 2025 | 86 | 36,961 (0%) | 0% | 70.7 | 6,083 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Sale of securities on an exchange or to another person at price $ 72.63 per share. | 27 Mar 2025 | 19 | 36,817 (0%) | 0% | 72.6 | 1,380 | Common Stock |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 13,800 | 13,800 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 6,400 | 41,400 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Michael Huang | Sr. VP of Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 35,000 | 35,000 (0%) | 0% | 0 | Common Stock | |
| Frequency Therapeutics Inc | Michael Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 14,846 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Michael Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 14,846 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Michael Huang | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Michael Huang | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Michael Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 14,846 | 14,846 | - | - | Stock Option | |
| Viracta Therapeutics Inc | Michael Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Frequency Therapeutics Inc | Michael Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 14,846 | 14,846 | - | - | Stock Option |